MedTrace Logo

PRECISion medicinE Across the Disease Continuum to Prevent and Treat Rheumatoid Arthritis

NCT04482335 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2021-10-06

No results posted yet for this study

Summary

The study will recruit patients referred to the Rheumatology Out-patient departments. Patients will be recruited to the study or control groups (healthy or disease controls who will be age and sex-matched) as needed. The study will first open to recruitment at Manchester University Hospitals NHS Foundation Trust and then open at other NHS Trusts. Patients will be asked to participate in longitudinal (clinical/imaging/biosample) data and/or sample collection that will improve our understanding of underlying disease mechanisms and identify improved diagnostic, prognostic and predictive biomarkers to understand progression of disease and drug response or resistance.

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • University of Manchester

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-15
Primary Completion
2025-10-01
Completion
2025-10-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04482335 on ClinicalTrials.gov